产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
A999003 | Anti-OSMR Reference Antibody (vixarelimab), Anti-OSMR Reference Antibody (vixarelimab), |
|||
A999004 | Anti-Osteopontin Reference Antibody (ASK8007), Anti-Osteopontin Reference Antibody (ASK8007), |
|||
A999005 | Anti-OX2R / CD200R1 Reference Antibody (Janssen patent anti-CD200R1), Anti-OX2R / CD200R1 Reference Antibody (Janssen patent anti-CD200R1), |
|||
A999006 | Anti-oxLDL Reference Antibody (Okayama U. patent anti-oxLDL), Anti-oxLDL Reference Antibody (Okayama U. patent anti-oxLDL), |
|||
A999007 | Anti-oxLDL Reference Antibody (orticumab), Anti-oxLDL Reference Antibody (orticumab), |
|||
A999072 | Anti-P-Selectin / CD62p Reference Antibody (crizanlizumab), Anti-P-Selectin / CD62p Reference Antibody (crizanlizumab), |
|||
A999073 | Anti-P-Selectin / CD62p Reference Antibody (inclacumab), Anti-P-Selectin / CD62p Reference Antibody (inclacumab), |
|||
A999008 | Anti-PAC1 Reference Antibody (zelminemab), Anti-PAC1 Reference Antibody (zelminemab), |
|||
A999009 | Anti-PACAP38 Reference Antibody (Lilly patent anti-PACAP), Anti-PACAP38 Reference Antibody (Lilly patent anti-PACAP), |
|||
A999010 | Anti-PAR2 Reference Antibody (Amgen patent anti-PAR-2), Anti-PAR2 Reference Antibody (Amgen patent anti-PAR-2), |
|||
A999011 | Anti-PAR2 Reference Antibody (PAR650097), Anti-PAR2 Reference Antibody (PAR650097), |
|||
A999012 | Anti-PAR2 Reference Antibody (Regeneron patent anti-PAR-2), Anti-PAR2 Reference Antibody (Regeneron patent anti-PAR-2), |
|||
A999013 | Anti-PCLA Reference Antibody (U.Penn. patent anti-PCLA), Anti-PCLA Reference Antibody (U.Penn. patent anti-PCLA), |
|||
A999014 | Anti-PCSK9 Reference Antibody (alirocumab), Anti-PCSK9 Reference Antibody (alirocumab), |
|||
A999015 | Anti-PCSK9 Reference Antibody (bococizumab), Anti-PCSK9 Reference Antibody (bococizumab), |
|||
A999016 | Anti-PCSK9 Reference Antibody (Boehringer anti-PCSK9), Anti-PCSK9 Reference Antibody (Boehringer anti-PCSK9), |
|||
A999017 | Anti-PCSK9 Reference Antibody (ebronucimab), Anti-PCSK9 Reference Antibody (ebronucimab), |
|||
A999018 | Anti-PCSK9 Reference Antibody (evolocumab), Anti-PCSK9 Reference Antibody (evolocumab), |
|||
A999019 | Anti-PCSK9 Reference Antibody (frovocimab), Anti-PCSK9 Reference Antibody (frovocimab), |
|||
A999020 | Anti-PCSK9 Reference Antibody (lodelcizumab), Anti-PCSK9 Reference Antibody (lodelcizumab), |